FDA approves new painkiller that shows promise and challenges of opioid alternatives
Vertex has attracted interest from Wall Street for its ambitious drug pipeline that involves winning FDA approval for ...
These Stocks Are Moving the Most Today: Apple, Intel, Visa, Deckers, Atlassian, Vertex, Exxon, and More
Apple stock rises after the tech giant posts better-than-expected earnings and guides for solid growth, while Intel’s ...
Vertex Stock Jumps After Non-Opioid Painkiller Gets FDA Approval
Shares of Vertex Pharmaceuticals rose 8% in off-hours trading after the pharmaceutical company won U.S. approval for the [first new non-opioid painkiller in decades]( ...
NewsX26m
How Much Will Newly Non-Opioid Painkiller Approved By FDA Cost You?
The FDA granted approval for Journavx after clinical trials demonstrated its effectiveness in post-surgical pain relief ...
The Tokenist35m
Vertex Pharmaceuticals Stock Soars as Non-Opiod Pain Treatment Gets FDA Nod
Vertex Pharmaceuticals' newly FDA-approved non-opioid analgesic, Journavx, offers a groundbreaking alternative for managing ...
WFMJ55m
FDA approves non-opioid pain medication
The Food and Drug Administration on Tuesday approved Journavx, the first drug in a new class of non-opioid pain medications, ...